Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microchimerism in the human brain, quantitative assessment and single nuclei profiling establish cell types and diversity.

bioRxiv : the preprint server for biology·2026
Same author

The relationship between infant feeding types, gut microbiome, intestinal inflammation, and neurodevelopment in a neonatal piglet model.

JPEN. Journal of parenteral and enteral nutrition·2025
Same author

Repeated Administration of Pharmaceutical-Grade Medium-Chain Triglycerides, a Common Pharmacologic Excipient, Confers Dose-Dependent Toxicity by the Intraperitoneal but Not Oral Route in Mice.

Journal of the American Association for Laboratory Animal Science : JAALAS·2025
Same author

Physiological and injury-induced microglial dynamics across the lifespan.

Cell reports·2025
Same author

Repeated administration of pharmaceutical-grade medium chain triglycerides, a common pharmacologic excipient, confers dose-dependent toxicity by the intraperitoneal but not oral route in mice.

bioRxiv : the preprint server for biology·2024
Same author

Glial 'omics in ischemia: Acute stroke and chronic cerebral small vessel disease.

Glia·2024
Same journal

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026
Same journal

Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway.

Neurochemical research·2026
Same journal

Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation.

Neurochemical research·2026
Same journal

Long-Term Impact of Early-Life Stress on Hippocampal Apoptotic Gene Expression in BALB/c Mice.

Neurochemical research·2026
Same journal

Minute-Resolution Sampling Reveals Rapid and Stimulus-Specific IL-1β Dynamics During Acute Epileptiform Activity.

Neurochemical research·2026
Same journal

Sex-Specific Hippocampal Phosphoproteomic Features Associated with Stress-Induced Phenotypes in Mice Exposed to Chronic Restraint Stress.

Neurochemical research·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

10.4K

Microglial Interferon Signaling and White Matter.

Ashley McDonough1, Richard V Lee1, Jonathan R Weinstein2

  • 1Department of Neurology, University of Washington, Seattle, WA, 98195, USA.

Neurochemical Research
|May 26, 2017
PubMed
Summary
This summary is machine-generated.

Type I interferons (IFNs) critically regulate microglia, the brain's immune cells. Dysregulated IFN signaling causes neurological diseases by impairing microglial function, highlighting IFNs as therapeutic targets.

Keywords:
InterferonsMicrogliaPseudo-TORCH syndromeUsp18White matter

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.1K
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.8K

Related Experiment Videos

Last Updated: Mar 1, 2026

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

10.4K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.1K
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.8K

Area of Science:

  • Neuroimmunology
  • Cellular and Molecular Neuroscience

Background:

  • Microglia are central to CNS immune responses and neuroinflammation.
  • Type I interferons (IFNs), including IFNα and IFNβ, are key immune cytokines influencing microglial function.
  • IFN activity impacts neuroinflammation, ischemia, neurodegeneration, and blood-brain barrier integrity.

Purpose of the Study:

  • To explore the role of type I IFNs in regulating microglial function in neurological disorders.
  • To investigate the consequences of dysregulated IFN signaling in genetic models and human diseases.
  • To highlight microglia and IFN signaling as potential therapeutic targets.

Main Methods:

  • Review of existing literature on type I IFNs, microglia, and neurological diseases.
  • Analysis of data from mouse models with genetic deficiencies (e.g., USP18).
  • Examination of human genetic disorders with dysregulated IFN signaling (e.g., pseudo-TORCH syndrome).

Main Results:

  • Type I IFNs modulate microglial phenotype, phagocytosis, and blood-brain barrier integrity.
  • USP18 deficiency and pseudo-TORCH syndrome demonstrate severe neurological phenotypes linked to dysregulated IFN signaling and microglial dysfunction.
  • Interferonopathies result in white matter pathology and pro-inflammatory microglial activation.

Conclusions:

  • Type I IFN signaling is crucial for maintaining microglial homeostasis and CNS health.
  • Dysregulation of IFN signaling leads to microgliopathies and severe neurological diseases.
  • Targeting IFN signaling pathways presents a promising therapeutic strategy for neurological disorders like MS and AD.